Aroa Biosurgery Limited (ARX.AX) — Stock Score Summary

Aroa Biosurgery Limited (ARX.AX) has a MoatMap StockRank of 53/100 based on Quality (70/100), Value (31/100), and Momentum (38/100) factor scores. The current signal is HOLD. Small-cap medical device company with promising soft-tissue products but lacking the scale, cash flow generation, and valuation margin of safety we require.

Aroa Biosurgery Limited develops, manufactures, and markets medical devices for complex wound healing and soft tissue reconstruction using its proprietary extracellular matrix technology. The company possesses a strong clinical and economic value proposition with FDA-cleared products that are significantly more cost-effective than traditional biologic scaffolds. It is a vertically integrated regenerative medicine company with established commercial distribution channels in the United States.

Key Financial Metrics

Price$0.44
Market Cap$173M
P/E (TTM)64.50
P/E (Forward)22.19
Price/Book2.70
Return on Equity4.9%
Return on Invested Capital-2.1%
Debt/Equity6.42
Gross Margin85.5%
Operating Margin12.0%
Revenue Growth29.5%
Free Cash Flow$3M

Aroa Biosurgery Limited operates in the Medical Devices industry, part of the Healthcare sector (New Zealand).

Frequently Asked Questions

What is Aroa Biosurgery Limited’s (ARX.AX) StockRank?
MoatMap’s StockRank for Aroa Biosurgery Limited (ARX.AX) is 53/100, with a Hold signal. It is a composite of Quality (70), Value (31), and Momentum (38) factor ranks across MoatMap’s 19,000+ stock universe.
Does Aroa Biosurgery Limited have an economic moat?
Aroa Biosurgery Limited (ARX.AX) has a Quality factor score of 70/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Aroa Biosurgery Limited a buy, hold, or sell?
MoatMap’s current signal for Aroa Biosurgery Limited (ARX.AX) is Hold, based on a StockRank of 53/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Aroa Biosurgery Limited in?
Aroa Biosurgery Limited (ARX.AX) operates in the Healthcare sector, specifically the Medical Devices industry (New Zealand).
Browse all ranked stocksARX.AX deep dive reportAI ChampionsHow we score stocksSense-check another stock